The document outlines the background and reasons for granting the respondent Apotex leave to file an affidavit in response to affidavits filed by the applicant Bayer A.G. in their proceedings under the Patented Medicines (Notice of Compliance) Regulations. The court permits the filing of the affidavit in the interests of justice to assist the court and to avoid serious prejudice to either party. The order also extends the time for cross-examination and filing the applicant's record to new dates.